Claims
- 1. A conjugate of D-GL and a cell surface binding molecule wherein the cell surface binding molecule is a toxin, pain suppressant, antibiotic or cell growth inhibitor.
- 2. A method for treating a patient for disease or disorder comprising administering to the patient a conjugate of D-GL and a cell surface binding molecule wherein the cell surface binding molecule is a toxin, pain suppressant, antibiotic or cell growth inhibitor that is effective in treating the disease or disorder.
Parent Case Info
This application is a division of application Ser. No. 07/254,597 filed, Oct. 7, 1988 now U.S. Pat. No. 4,950,469 which is a division of application Ser. No. 869,393 filed Mar. 30, 1986 and now abandoned.
US Referenced Citations (6)
Non-Patent Literature Citations (2)
Entry |
Katz, "Hapten-Specific Tolerance Induced by the DNP Derivative of D-Glutamic Acid and D-Lysine (D-GL)Copolymer" Immunological Tolerance, Academic Press, 1974. |
Benacerraf et al., "Failure to Induce Tolerance to 2,4-Dinitrochlorobenzene Contact Sensitivity with a 2,4-Dinitrophenyl (DNP) Conjugate at Copolymer of D-Glutamic Acid and D-Lysine, a Specific Tolerance for DNP B Cells", the J. of Immunol., vol. 112, No. 3, Mar. 1974, pp. 1158-1163. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
869393 |
May 1986 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
254597 |
Oct 1988 |
|